1. Home
  2. SKK vs MIRM Comparison

SKK vs MIRM Comparison

Compare SKK & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKK
  • MIRM
  • Stock Information
  • Founded
  • SKK 2013
  • MIRM 2018
  • Country
  • SKK Singapore
  • MIRM United States
  • Employees
  • SKK N/A
  • MIRM N/A
  • Industry
  • SKK
  • MIRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKK
  • MIRM Health Care
  • Exchange
  • SKK NYSE
  • MIRM Nasdaq
  • Market Cap
  • SKK 12.3M
  • MIRM 1.9B
  • IPO Year
  • SKK 2024
  • MIRM 2019
  • Fundamental
  • Price
  • SKK $0.73
  • MIRM $42.54
  • Analyst Decision
  • SKK
  • MIRM Strong Buy
  • Analyst Count
  • SKK 0
  • MIRM 11
  • Target Price
  • SKK N/A
  • MIRM $58.55
  • AVG Volume (30 Days)
  • SKK 115.7K
  • MIRM 437.9K
  • Earning Date
  • SKK 02-14-2025
  • MIRM 05-12-2025
  • Dividend Yield
  • SKK N/A
  • MIRM N/A
  • EPS Growth
  • SKK N/A
  • MIRM N/A
  • EPS
  • SKK N/A
  • MIRM N/A
  • Revenue
  • SKK $8,631,000.00
  • MIRM $336,888,000.00
  • Revenue This Year
  • SKK N/A
  • MIRM $29.51
  • Revenue Next Year
  • SKK N/A
  • MIRM $20.27
  • P/E Ratio
  • SKK N/A
  • MIRM N/A
  • Revenue Growth
  • SKK N/A
  • MIRM 80.76
  • 52 Week Low
  • SKK $0.61
  • MIRM $23.83
  • 52 Week High
  • SKK $11.45
  • MIRM $54.23
  • Technical
  • Relative Strength Index (RSI)
  • SKK N/A
  • MIRM 53.41
  • Support Level
  • SKK N/A
  • MIRM $38.22
  • Resistance Level
  • SKK N/A
  • MIRM $39.87
  • Average True Range (ATR)
  • SKK 0.00
  • MIRM 1.92
  • MACD
  • SKK 0.00
  • MIRM 0.49
  • Stochastic Oscillator
  • SKK 0.00
  • MIRM 93.09

About SKK SKK HOLDINGS LIMITED

SKK Holdings Ltd is a civil engineering service provider that specializes in subsurface utility works in Singapore. It construct and maintain various public works and infrastructure projects that serve the society and the environment. Its projects are primarily the subsurface work related to projects undertaken by the Public Utilities Board (PUB) and Singapore Telecommunications Limited. The nature of these projects is related to repairing of pumping mains, sewer maintenance and pipe cable laying.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: